Tag: vortioxetine
QuarterWatch Reports: Perspectives on Emerging Drug Risks
A new issue of QuarterWatch critiques the recent Ciprani meta-analysis on antidepressants and reports on the adverse effects of the newest antidepressant, vortioxetine.
Report →
Dr. Nardo Pens Letter to FDA on Brintellix
Dr. Nardo, on his 1boringoldman blog, recaps his letter to the FDA concerning his findings after reviewing the research data on the new antidepressant...
“In Surprise Decision, FDA Blocks Crucial Cognitive Claim for Takeda’s Brintellix”
Takeda and Lundbeck had prepared to advertise that their latest antidepressant Brintellix (Vortioxetine) could give patients a cognitive boost and help them think and...
Latest Antidepressant a Case Study in Institutional Corruption
A new study tracks the approval of the latest antidepressant, vortioxetine, by the Federal Drug Administration (FDA) and the European Medicines Agency (EMA). The...
